Michael Underriner, MD

Dr. Telonis is a board-eligible adult psychiatrist who had been in practice for four years. Her focus is on using a collaborative approach and shared-decision making to help patients achieve their treatment goals. Dr. Telonis typically provides monthly 30-minute follow-ups with a focus on medication management and supportive therapy. In some instances, she may recommend a separate therapist to help facilitate the best care possible. Dr. Telonis earned her bachelor's degree in History of Art from Johns Hopkins University and then completed her master's at King's College London in international development with a focus on climate change. She received her medical degree from St. George's University School of Medicine and completed her psychiatry training at Mount Sinai Morningside and West Hospitals. Dr. Telonis has worked with a diverse patient population while training at Mount Sinai Morningside.‍

Dr. Chuck Stanfa is a board-certified psychiatrist who genuinely enjoys helping people.  He has practiced in a wide range of settings, including both outpatient and inpatient during the past 10 years.  He studied medicine at the University of Medicine and Dentistry of New Jersey.  He completed his psychiatry residency training at Drexel University College of Medicine in Philadelphia.  He went on to complete a Community Psychiatry Fellowship at the University of Pennsylvania and has continued to serve the greater Philadelphia area.  

Dr. Stanfa tries to take a person-centered approach to psychiatry.  He spends time getting to know each person and is easy to talk to.  He takes a collaborative approach to medication management and provides supportive therapy.  He believes that the relationship is one of the most important aspects of treatment.  He is open to working with most diagnoses including Mood Disorders, Anxiety Disorders, PTSD, ADHD, Personality Disorders, and others.  He will work with each person to develop a treatment plan that works for them.

‍

Dr. Caitlin Schroen completed her Psychiatry residency at Rutgers Robert Wood Johnson Medical School in Piscataway, NJ. She received her bachelor's degree in Psychology from Fordham University and then attended medical school at the Lewis Katz School of Medicine at Temple University. Dr. Schroen provides psychiatric services to adults ages 18 and older. She focuses on medication management and psychoeducation, often along with supportive therapy. With a patient-centered approach, Dr. Schroen believes in fostering a safe and non-judgmental environment where individuals can openly discuss their mental health concerns. Dr. Schroen is well-versed in a wide spectrum of psychiatric conditions and offers evidence-based treatments tailored to each patient's unique needs. She has a particular interest in treating mood disorders, anxiety disorders, OCD, and ADHD. Dr. Schroen is passionate about reducing the stigma surrounding mental health and strives to provide the highest quality care to help individuals lead happier and more fulfilling lives.

Dr. Jiang is a board-certified adult psychiatrist. His practice focuses on medication management and supportive therapy. His major goal is for treatment to be patient centered, with a focus on high quality, evidence-based care in the safest and most meaningful way. Dr. Jiang completed an undergraduate degree at the University of California, Los Angeles. He received his medical degree from Oakland University William Beaumont, School of Medicine. He then completed his psychiatry residency at Loyola University Medical Center. Dr. Jiang's areas of interest include depression and post-traumatic stress disorder.‍

Dr. Viga Naik takes a holistic approach when practicing, understanding the importance of an integrative treatment care model. She believes optimal patient care goes beyond psychopharmacology and requires incorporation of psychotherapy and psychosocial intervention. She is a strong advocate for her patients, dedicated to being an educator of mental illness to break self, societal, and systemic stigmas. She believes that a strong therapeutic alliance between clinician and patient is essential. She works on creating a safe and empathetic environment while providing psychoeducation to patients, empowering them to play an active role in their treatment. Dr. Naik is an adult psychiatrist with specializations in Addiction Psychiatry and Consultation-Liaison Psychiatry, also known as psychosomatic medicine. She completed her residency training at New York Medical College and fellowship training at the Mount Sinai Health Systems located at Bronx Care and Beth Israel Hospital. She has worked in both inpatient and many outpatient specialty clinics such as psych/oncology, transplant, collaborative-care, medication assistance treatment, music and medicine, and gender affirmation surgery treating patients with comorbid mental illness and substance use disorders as well as comorbid mental illness and general medical conditions. Her practice focuses on medication management in combination with supportive therapy and providing psychoeducation to patients. She treats depression, anxiety, bipolar disorder, obsessive compulsive disorder, post-traumatic stress disorder, general anxiety disorder, substance use disorders and other associated psychiatric disorders.

Dr. Amber Blue is a board-certified psychiatrist trained in Adult Psychiatry. She completed her residency at Yale University. She offers medication management in 30-minute follow-up visits informed by her psychotherapy experience. Occasionally, she may believe additional therapy would be beneficial, and therefore, she recommends that you add a therapist to your care team for the best results. She has received specialized training in psychoanalytic psychotherapy at Columbia University and NYU. Over the past three years, Dr. Blue has worked in college student health centers and private practice. She has a wide range of experience in treating various mental illnesses including depression, bipolar disorder, anxiety, and OCD. Her approach is to educate clients on their mental health, available pharmacologic and psychotherapeutic options, and to collaborate with them in formulating an evidence-based treatment plan.